annual CFF:
$1.01B+$621.49M(+159.79%)Summary
- As of today (July 1, 2025), CRNX annual cash flow from financing activities is $1.01 billion, with the most recent change of +$621.49 million (+159.79%) on December 31, 2024.
- During the last 3 years, CRNX annual CFF has risen by +$757.76 million (+299.89%).
- CRNX annual CFF is now at all-time high.
Performance
CRNX Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$4.44M-$549.60M(-99.20%)Summary
- As of today (July 1, 2025), CRNX quarterly cash flow from financing activities is $4.44 million, with the most recent change of -$549.60 million (-99.20%) on March 31, 2025.
- Over the past year, CRNX quarterly CFF has dropped by -$389.14 million (-98.87%).
- CRNX quarterly CFF is now -99.20% below its all-time high of $554.04 million, reached on December 31, 2024.
Performance
CRNX quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$621.30M-$389.14M(-38.51%)Summary
- As of today (July 1, 2025), CRNX TTM cash flow from financing activities is $621.30 million, with the most recent change of -$389.14 million (-38.51%) on March 31, 2025.
- Over the past year, CRNX TTM CFF has dropped by -$160.74 million (-20.55%).
- CRNX TTM CFF is now -38.51% below its all-time high of $1.01 billion, reached on December 31, 2024.
Performance
CRNX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CRNX Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +159.8% | -98.9% | -20.6% |
| 3 y3 years | +299.9% | +149.3% | +144.2% |
| 5 y5 years | +10000.0% | -31.6% | +441.8% |
CRNX Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +728.5% | -99.2% | +3758.3% | -38.5% | +4234.7% |
| 5 y | 5-year | at high | >+9999.0% | -99.2% | +2908.2% | -38.5% | +4234.7% |
| alltime | all time | at high | >+9999.0% | -99.2% | +964.9% | -38.5% | >+9999.0% |
CRNX Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $4.44M(-99.2%) | $621.30M(-38.5%) |
| Dec 2024 | $1.01B(+159.8%) | $554.04M(+866.5%) | $1.01B(+104.4%) |
| Sep 2024 | - | $57.33M(+943.1%) | $494.32M(-36.2%) |
| Jun 2024 | - | $5.50M(-98.6%) | $774.87M(-0.9%) |
| Mar 2024 | - | $393.57M(+937.8%) | $782.03M(+101.1%) |
| Dec 2023 | $388.94M(+218.9%) | $37.92M(-88.8%) | $388.94M(+10.8%) |
| Sep 2023 | - | $337.88M(+2569.3%) | $351.13M(+2349.8%) |
| Jun 2023 | - | $12.66M(+2515.3%) | $14.33M(-88.1%) |
| Mar 2023 | - | $484.00K(+320.9%) | $120.67M(-1.1%) |
| Dec 2022 | $121.96M(-51.7%) | $115.00K(-89.3%) | $121.96M(-57.3%) |
| Sep 2022 | - | $1.08M(-99.1%) | $285.70M(-4.8%) |
| Jun 2022 | - | $118.99M(+6584.9%) | $300.09M(+18.0%) |
| Mar 2022 | - | $1.78M(-98.9%) | $254.40M(+0.7%) |
| Dec 2021 | $252.68M(+120.5%) | $163.86M(+959.7%) | $252.68M(+184.2%) |
| Sep 2021 | - | $15.46M(-78.9%) | $88.92M(+21.3%) |
| Jun 2021 | - | $73.30M(>+9900.0%) | $73.30M(-32.2%) |
| Mar 2021 | - | $57.00K(-41.2%) | $108.15M(-5.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $114.57M(>+9900.0%) | $97.00K(-161.4%) | $114.57M(+0.1%) |
| Sep 2020 | - | -$158.00K(-100.1%) | $114.49M(-0.2%) |
| Jun 2020 | - | $108.15M(+1568.5%) | $114.67M(+1656.3%) |
| Mar 2020 | - | $6.48M(>+9900.0%) | $6.53M(+9644.8%) |
| Dec 2019 | $67.00K(-100.0%) | $17.00K(-22.7%) | $67.00K(+13.6%) |
| Sep 2019 | - | $22.00K(+175.0%) | $59.00K(-99.9%) |
| Jun 2019 | - | $8000.00(-60.0%) | $107.23M(+0.5%) |
| Mar 2019 | - | $20.00K(+122.2%) | $106.71M(-37.3%) |
| Dec 2018 | $170.20M(+1339.6%) | $9000.00(-100.0%) | $170.20M(-4.0%) |
| Sep 2018 | - | $107.19M(<-9900.0%) | $177.26M(+153.0%) |
| Jun 2018 | - | -$513.00K(-100.8%) | $70.06M(-6.9%) |
| Mar 2018 | - | $63.51M(+798.2%) | $75.28M(+536.8%) |
| Dec 2017 | $11.82M(<-9900.0%) | $7.07M(<-9900.0%) | $11.82M(+148.8%) |
| Sep 2017 | - | -$10.00K(-100.2%) | $4.75M(-0.2%) |
| Jun 2017 | - | $4.71M(+9137.3%) | $4.76M(+9237.3%) |
| Mar 2017 | - | $51.00K | $51.00K |
| Dec 2016 | -$53.00K | - | - |
FAQ
- What is Crinetics Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals annual CFF year-on-year change?
- What is Crinetics Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly CFF year-on-year change?
- What is Crinetics Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals TTM CFF year-on-year change?
What is Crinetics Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of CRNX is $1.01B
What is the all time high annual CFF for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high annual cash flow from financing activities is $1.01B
What is Crinetics Pharmaceuticals annual CFF year-on-year change?
Over the past year, CRNX annual cash flow from financing activities has changed by +$621.49M (+159.79%)
What is Crinetics Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of CRNX is $4.44M
What is the all time high quarterly CFF for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high quarterly cash flow from financing activities is $554.04M
What is Crinetics Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, CRNX quarterly cash flow from financing activities has changed by -$389.14M (-98.87%)
What is Crinetics Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of CRNX is $621.30M
What is the all time high TTM CFF for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high TTM cash flow from financing activities is $1.01B
What is Crinetics Pharmaceuticals TTM CFF year-on-year change?
Over the past year, CRNX TTM cash flow from financing activities has changed by -$160.74M (-20.55%)